Need Help? Call 1­-866-­796-­7386
« back to stock screener

  RVNC stock: Revance Therapeutics Inc

Current Rating
Strong Sell

Previous Rating:

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$24.35
Market Cap
756.6M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
4.55
P/S
-
Dividend %
-
P/CF
503.7
P/FCF
-
Op. Cash Flow
-73.3K
FCF
-2.6
Op. Margin
-
Net Margin
-
ROE
-55.20%
ROI
-48.30%
ROA
-47.70%
EPS Growth
-6.40%
Current Ratio
9.8
Debt/Equity
1.10%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Aviragen Therapeutics Inc (AVIR) $0.63 - - 24.3M Strong Buy
Dyadic International, Inc. (DYAI) $1.43 - - 42.8M Strong Buy
Senomyx Inc. (SNMX) $0.65 - - 28.8M Strong Buy
DURECT Corporation (DRRX) $1.69 - - 233.7M Strong Buy
Digirad Corporation (DRAD) $3.30 - 6.30% 70.9M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More